Published in Hepatitis Weekly, April 3rd, 2006
"Success in resolving HCV infection has been correlated to vigorous, multispecific, and sustained CD8+ T-cell response in humans and chimpanzees.
"The efficacy of inducing T-cell-mediated immunity by recombinant serotype 5 adenovirus vector has been proven in many animal models of infectious diseases, but its immunogenicity can be negatively influenced by preexisting immunity against the vector itself," wrote S. Capone and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.